Regulation of renal proximal transport by angiotensin II (Ang II) is biphasic: low concentrations (picomolar to nanomolar) stimulate reabsorption, but higher concentrations (nanomolar to micromolar) inhibit reabsorption. Traditionally, the stimulatory effect has been attributed to activation of protein kinase C and/or a decrease in intracellular cAMP, whereas the inhibitory action has been attributed to the activation of phospholipase A 2 (PLA 2 ) and the subsequent release of arachidonic acid. The Ang II receptor subtype responsible for these effects and the intracellular signaling pathways involved are not completely understood. We isolated proximal tubules from wild-type, Ang II type 1A receptor (AT 1A )-deficient, and group IVA cytosolic phospholipase A 2 (cPLA 2 ␣)-deficient mice, and compared their responses to Ang II. In wild-type mice, we found that the stimulatory and inhibitory effects of Ang II on Na ϩ -HCO 3 Ϫ cotransporter activity are both AT 1 -mediated but that ERK activation only plays a role in the former. The stimulatory effect of Ang II was also observed in AT 1A -deficient mice, suggesting that this occurs through AT 1B . In contrast, the inhibitory effects of Ang II appeared to be mediated by cPLA 2 ␣ activation because high-concentration Ang II stimulated Na ϩ -HCO 3 Ϫ cotransporter activity when cPLA 2 ␣ activity was abrogated by pharmacological means or genetic knockout. Consistent with this observation, we found that activation of the cPLA 2 ␣/P450 pathway suppressed ERK activation. We conclude that Ang II activates ERK and cPLA 2 ␣ in a concentration-dependent manner via AT 1 , and that the balance between ERK and cPLA 2 ␣ activities determines the ultimate response to Ang II in intact proximal tubules.
Angiotensin II (Ang II) plays an important role in regulation of body fluid and sodium balance through modulation of renal tubular functions. In particular, Ang II has been known to regulate renal proximal transport in quite a specific manner. In 1977 Harris and Young reported that Ang II added into peritubular fluid regulates volume absorption from rat proximal tubules in a biphasic way; stimulation by low (picomolar to nanomolar) concentrations of Ang II and inhibition by high (nanomolar to micromolar) concentrations of Ang II. 1 Subsequent studies not only confirmed this unique mode of regulation in different experimental conditions but also revealed the similar biphasic regulation by luminal Ang II. [2] [3] [4] [5] [6] Ang II is generally thought to work as a stimulator of proximal transport. Because in situ proximal tubular fluid is reported to contain markedly high concentrations of Ang II, 7 however, inhibition by high concentrations of Ang II could also have some physiological relevance to the regulation of proximal tubular functions in vivo.
Traditionally, the stimulation by Ang II has been attributed to the activation of protein kinase C and/or the decrease in the intracellular cAMP level, whereas the inhibition by Ang II has been attributed to the activation of phospholipase A 2 (PLA 2 ) and the subsequent release of arachidonic acid. 6,8 -10 However, conflicting data have been reported as to the identity of receptor subtype(s) mediating the biphasic effects of Ang II. The role of mitogen-activated protein kinases (MAPK) in Ang II signaling in this nephron segment has been also incompletely understood. Thus, Douglas and colleagues, on the basis of data obtained from cultured rabbit proximal tubular cells, presented evidence that the extracellular signal-regulated kinase (ERK) pathway mediates the inhibitory effect of Ang II. They proposed that Ang II, via its type 2 receptor (AT 2 ), stimulates a membrane-associated PLA 2 that facilitates the release of arachidonic acid. Arachidonic acid, in turn, either through cytochrome P450 metabolites or directly, stimulates the ERK pathway. [11] [12] [13] [14] [15] [16] In sharp contrast to their proposal, however, several studies suggested that Ang II type 1 receptor (AT 1 ) mediates both stimulatory and inhibitory effects of Ang II. 10, 17 Our own data obtained from AT 1A -deficient mice also led us to conclude that AT 1 mediates the biphasic regulation in intact mouse proximal tubules. 18, 19 Furthermore, recent studies suggested that the ERK pathway might actually mediate the stimulatory effect of Ang II. 20, 21 Because commonly used PLA 2 inhibitors lack specificity, it also remains to be definitely determined which PLA 2 isoform is involved in the Ang II signaling. In this study we have tried to clarify these issues by comparing the responses to Ang II in isolated proximal tubules from wildtype, AT 1A -deficient, 22 and group IVA cytosolic PLA 2 (cPLA 2 ␣)-deficient mice. 23 Our results demonstrate that the ERK activation via AT 1 mediates only the stimulatory effect, whereas the cPLA 2 ␣ activation via AT 1 mediates the inhibitory effect independently of ERK. In addition, the loss of cPLA 2 ␣ activity either through pharmacological blockade or genetic knockout unmasks the AT 1 /ERK-mediated stimulation by high concentration of Ang II, indicating that the cPLA 2 ␣-dependent pathway works to suppress the ERK activation in intact proximal tubules. These results uncover a novel mechanism by which the relative activities of ERK and cPLA 2 ␣ determine the final responses of proximal tubules to Ang II.
RESULTS

Role of ERK in Wild-Type Mice
To examine the role of ERK in Ang II signaling in isolated proximal tubules from wild-type mice, we focused on the basolateral electrogenic Na ϩ -HCO 3 Ϫ cotransporter (NBC), which most likely originates from NBC1 24 and is one of the main target transporters of Ang II. 4, 5, 18 The NBC activity was estimated by the rate of cell pH decrease in response to sudden reduction of bath HCO 3 Ϫ concentrations and cell buffer capacity as described. 18 As previously reported, 18 addition of Ang II to bath (peritubular) fluid for 5 min modulated the NBC activity in the biphasic manner ( Figure 1A) . A specific AT 1 antagonist olmesartan (0.2 mol/L) completely inhibited both stimulatory and inhibitory effects of Ang II ( Figure 1B) , confirming our previous conclusion that AT 1 mediates the biphasic regulation of NBC activity. 18 Theoretically, high concentrations of Ang II might lead to the generation of other peptide products such as Ang-(1-7), which could transmit signals through AT 1 . We confirmed, however, that up to 10 Ϫ7 mol/L Ang-(1-7) had no significant effects on the NBC1 activity (data not shown), ruling out the involvement of this peptide. By contrast, a mitogen-activated protein kinase (MEK) inhibitor PD98059 (10 mol/L) completely inhibited the stimulatory effect of 10 Ϫ10 mol/L Ang II, but unaffected the inhibitory effect of 10 Ϫ6 mol/L Ang II ( Figure 1B ). Separate experiments confirmed that the addition of olmesartan or PD98059 did not affect the basal NBC activity. These results indicate that the ERK pathway is involved in the AT 1 -mediated stimulatory effect, whereas the AT 1 -mediated inhibitory effect is independent of the ERK pathway. To confirm the Ang II-mediated ERK activation, we analyzed the phosphorylation of ERK in kidney cortex samples. Brief (2 min) exposure to 10 Ϫ10 mol/L Ang II induced a significant ERK phosphorylation. However, higher concentrations of Ang II failed to induce the ERK phosphorylation ( Figure 1C ). In addition, the ERK phosphorylation by 10 Ϫ10 mol/L Ang II was blocked by olmesartan but not by a specific AT 2 inhibitor PD123319 ( Figure 1D ). PD98059 also completely inhibited the ERK phosphorylation by 10 Ϫ10 mol/L Ang II ( Figure 1D ). The ERK phosphorylation was maximum at 2 min, but still visible at 10 min after exposure to Ang II (data not shown). These results indicate that only a low concentration (10 Ϫ10 mol/L) of Ang II rapidly activates ERK via AT 1 in wild-type mice, which is responsible for the stimulation of NBC activity.
Role of ERK in AT 1A -Deficient Mice
To further confirm the receptor subtype(s) mediating the ERK activation, we examined the effects of Ang II in AT 1A -deficient mice. 22 As in the previous study, 18 only the stimulation of NBC by 10 Ϫ6 mol/L Ang II was detected ( Figure 2A ). This stimulation was completely blocked by both olmesartan and PD98059 ( Figure 2B ). These results are consistent with a view that Ang II activates the NBC activity through the AT 1B /ERK pathway in AT 1A -deficient mice. Because AT 1B is known to be expressed at much lower levels than AT 1A in proximal tubules, 25 as much as 10 Ϫ6 mol/L Ang II would be required to activate ERK in AT 1A -deficient mice. Consistent with this interpretation, only 10 Ϫ6 mol/L Ang II induced the significant ERK phosphorylation ( Figure 2C ), and this phosphorylation was blocked by olmesartan but not by PD123319 ( Figure 2D ). Taken together with the results in wild-type mice, we can conclude that the ERK activation is mediated via AT 1 and not via AT 2 , and it is involved only in the stimulatory effect of Ang II.
To obtain an estimate of relative abundance of AT 1 isoforms, we performed reverse-transcriptase (RT) PCR analysis on isolated proximal tubules. As shown in Figure 2E , the PCR product amplified from the AT 1 common region was clearly detected in wild-type but not in AT 1A -deficient mice. On the other hand, the PCR product amplified from the AT 1B -specific region was detected in both wild-type and AT 1A -deficient mice. The reason why the RT-PCR analysis with the AT 1 common primers failed to detect AT 1B mRNA in AT 1A -deficient mice remained speculative. It is possible that the amplification efficiency of RT-PCR may vary depending on primer sequences. Nevertheless, these results confirm that the expression of AT 1B mRNA is extremely low compared with that of AT 1A mRNA in proximal tubules.
Role of cPLA 2 in Wild-Type Mice
Because cPLA 2 plays a central role in the liberation of arachidonic acid and subsequent biosynthesis of eicosanoids in a variety of tissues, we next tested a potential role of cPLA 2 in wild-type mice by using a relatively specific cPLA 2 inhibitor AACOCF 3 and a more specific cPLA 2 inhibitor pyrrophenone. 26 In the presence of AACOCF 3 (10 mol/L), the biphasic regulation of Ang II was lost, and all of the concentrations of Ang II (from 10 Ϫ10 to 10 Ϫ6 mol/L) showed the stimulation of NBC activity ( Figure 3A ). In the presence of pyrrophenone (1 mol/L), the virtually identical stimulation of NBC was detected by all of the concentrations of Ang II ( Figure 3B ), supporting the role of cPLA 2 in inhibitory effect of Ang II. On the other hand, in the presence of cytochrome P450 inhibitor ketoconazole (15 mol/L), all of the concentrations of Ang II again showed only the stimulatory effect ( Figure 3C ). We confirmed that the basal NBC activity was unaffected by the addition of AACOCF 3 , pyrrophenone, or ketoconazole. These results strongly suggest that P450 metabolites are involved in the cPLA 2 -mediated inhibitory pathway.
Another P450 inhibitor econazole was also reported to convert the inhibition by 10 Ϫ7 mol/L Ang II to the stimulation in cultured proximal tubular cells. 6 However, the mechanism underlying such conversion remained unknown. We hypothesized that the inhibition of cPLA 2 /P450 pathway might unmask the AT 1 -mediated ERK activation. In support of this hypothesis, the stimulatory effect of 10 Ϫ6 mol/L Ang II in presence of AACOCF 3 was totally suppressed by both olmesartan and PD98059 ( Figure 3D ). Furthermore, in the presence of AACOCF 3 ( Figure 3E ) or ketoconazole ( Figure 3F ), the significant ERK phosphorylation was detected by all of the concentrations of Ang II. A very similar result was obtained in the presence of pyrrophenone (data not shown). Contrary to the proposal by Douglas and colleagues, [11] [12] [13] [14] these results indicate that the cPLA 2 /P450 pathway actually works to suppress the AT 1 -mediated ERK activation in intact proximal tubules.
Ang II Effects in cPLA 2 ␣-Deficient Mice There are at least four cPLA 2 isoforms in mammals (cPLA 2 ␣, cPLA 2 ␤, cPLA 2 ␥, cPLA 2 ␦), which have the conserved catalytic domain. 27 To identify the cPLA 2 isoform involved in the Ang II signaling in proximal tubules, we examined the effects of Ang II in cPLA 2 ␣-deficient mice. 23 The baseline NBC1 activity estimated by rate of cell pH decrease and buffer capacity was comparable in wild-type (95.3 Ϯ 1.8 mmol/min, n ϭ 40) and cPLA 2 ␣-deficient mice (92.5 Ϯ 1.7 mmol/min, n ϭ 30). In cPLA 2 ␣-deficient mice, however, all of the concentrations of Ang II stimulated the NBC activity ( Figure 4A ). The AT 1 /ERK pathway mediated this stimulation because it was completely suppressed by both olmesartan and PD98059 ( Figure 4B ). An altered density of AT 1 in cPLA 2 ␣-deficient mice cannot explain the lack of inhibitory effect of Ang II because the AT 1 -mediated intracellular Ca 2ϩ increase 18 was preserved in these mice ( Figure 4C ). Indeed, Ͼ10
Ϫ8 mol/L Ang II was required to induce a spike-like cell Ca 2ϩ increase in both mice, consistent with our previous observation in wild-type mice. 18 In addition, the addition of arachidonic acid (0.1 mol/L) as well as 5,6-epoxyeicosatrienoic acid (EET, 0.1 mol/L) decreased the NBC1 activity comparably in wild-type and cPLA 2 ␣-deficient mice ( Figure 4D ), which indicates that the inhibitory response to P450 metabolites is also preserved in these mice. Taken together with the results obtained by pharmacological blockade of cPLA 2 ␣, we can now conclude that cPLA 2 ␣ is the cPLA 2 isoform responsible for the inhibitory effect of Ang II, and that the absence of cPLA 2 ␣ unmasks the AT 1 -mediated ERK activation. Consistent with this view, all of the concentrations of Ang II induced the significant ERK phosphorylation in cPLA 2 ␣-deficient mice (Figure 4E) , and this phosphorylation was blocked by olmesartan ( Figure 4F ). The addition of EET did not induce a significant ERK phosphorylation in both wild-type and cPLA 2 ␣-deficient mice ( Figure 4G ), consistent with a inhibitory role of this substance in intact proximal tubules.
Luminal Ang II Effects
The results thus far clearly show that the inhibitory effect of 
BASIC RESEARCH www.jasn.org
Ang II added to the basolateral side is dependent on the Ca 2ϩ -dependent PLA 2 isoform cPLA 2 ␣. On the other hand, Ang II is also known to exert the biphasic effects from the luminal side. 3, 19 Interestingly, several studies suggested that other isoforms such as Ca 2ϩ -independent PLA 2 28 or Ca 2ϩ -dependent membrane-associated PLA 2 11,13 might be involved in the responses to luminal Ang II. To clarify the role of cPLA 2 ␣ in luminal Ang II actions, we finally compared the responses to Ang II added into luminal fluid in wild-type and cPLA 2 ␣-deficient mice. To accomplish this task, we applied the microspectrofluorometric method, 29 and measured the rate of bicarbonate absorption (JHCO 3 Ϫ ). In wild-type mice, luminal Ang II showed the biphasic effects ( Figure 5A ), which was shown to be exclusively mediated by the luminal AT 1 . 19 The control JHCO 3 Ϫ value in cPLA 2 ␣-deficient mice (12.5 Ϯ 0.3 pmol/cm s, n ϭ 22) was very similar to that in wild-type mice (12.8 Ϯ 0.2 pmol/cm s, n ϭ 23). In cPLA 2 ␣-deficient mice, however, the inhibitory effect of luminal Ang II was lost, and all of the concentrations of Ang II showed only the stimulation ( Figure 5B ). These results indicate that cPLA 2 ␣ also mediates the inhibitory effect of luminal Ang II.
DISCUSSION
We previously concluded that AT 1 , expressed in either the basolateral or luminal membranes, mediates the biphasic regulation of proximal transport. 18, 19 The present study demonstrates that the ERK pathway mediates only the stimulatory effect of Ang II, while the cPLA 2 ␣/P450 pathway mediates the inhibitory effect of Ang II. Furthermore, the activation of cPLA 2 ␣ by high concentration of Ang II rather prevents the ERK activation, which should have occurred in the absence of cPLA 2 ␣ activity. From these results, we conclude that Ang II activates both ERK and cPLA 2 ␣ with different concentration dependency via AT 1 , and that the balance between ERK and cPLA 2 ␣ activities determines the final responses to Ang II in intact proximal tubules. Ang II is coupled to a variety of signaling cascades depending on cell types, and both stimulatory 20, 21 and inhibitory 12 roles of ERK have been suggested in the regulation of proximal transport by Ang II. Our study clearly shows that the activation of ERK via AT 1 mediates only the stimulatory effect in wild-type mice ( Figure  1) . In AT 1A -deficient mice, very high concentration (10 Ϫ6 mol/L) of Ang II was required to induce the PD98059-sensitive stimulation of NBC activity (Figure 2) . AT 1A and AT 1B are pharmacologically indistinguishable, 18 and the expression of AT 1B in proximal tubules is much less than that of AT 1A as previously reported, 25 and confirmed in our study. Accordingly, the most likely explanation would be that the low expression of AT 1B mediates the NBC stimulation by 10 Ϫ6 mol/L Ang II in AT 1A -deficient mice, and that both AT 1A and AT 1B can transmit the Ang II signaling to ERK activation. In American opossum kidney cells, the nonreceptor tyrosine kinase proline-rich tyrosine kinase 2 (Pyk2) is suggested to play a central role in coupling the Ang II signaling to the downstream activation of Src family kinase/ERK pathway, resulting in the stimulation of NBC activity. 20 It is unknown at present whether the similar signaling cascade exists in intact proximal tubules.
Several different PLA 2 isoforms such as Ca 2ϩ -independent PLA 2 or membrane-associated PLA 2 have been proposed to mediate the Ang II actions on proximal transport. 11, 13, 28 In the absence of specific inhibitors, however, it would be rather difficult to make a firm conclusion as to which PLA 2 isoform is really important. Our study unequivocally shows that cPLA 2 ␣ plays a critical role in the AT 1 -mediated inhibitory effect. Although a stimulatory role of mepacrine-sensitive PLA 2 was suggested in the luminal Ang II actions, 3, 28 our results indicate that cPLA 2 ␣ also mediates the inhibition by luminal Ang II ( Figure 5 ). We cannot totally exclude the possibility, however, that other PLA 2 isoforms may have some roles in Ang II-signaling in different experimental conditions. cPLA 2 ␣ preferentially catalyzes the hydrolysis of sn-2 position of glycerophospholipids to release arachidonic acid, which in turn is metabolized to prostaglandins by the cyclooxgenase pathway and to leukotriens by the 5-lipoxygenase pathway. Renal proximal tubules, on the other hand, abundantly express the cytochrome P450 epoxygenase, 30 and the arachidonic acid metabolites through this pathway, mainly 5,6-EET, are involved in the inhibitory effect of Ang II. 6, 10 A defect in AQP1 water channel expression in renal proximal tubules was found in the old but not young cPLA 2 ␣ mice. 31 Our data show that the renal proximal tubules from young cPLA 2 ␣ mice do not have any defects in the baseline NBC activity, the transepithelial bicarbonate transport capacity, the AT 1 and downstream signaling cascade leading to intracellular Ca 2ϩ increase, and the sensitivity to P450 metabolites.
Our study indicates that Ang II activates ERK and cPLA 2 ␣ via AT 1 with different concentration dependency, and that this difference is the key determinant of biphasic regulation by Ang II. Our data also indicate that the cPLA 2 ␣/P450 pathway, while mediating the inhibitory effect of Ang II independently of ERK, actually suppresses the ERK activation by Ang II. By contrast, Douglas and colleagues proposed that AT 2 mediates the activation of membrane associated PLA 2 leading to the downstream ERK activation. [11] [12] [13] Although it is rather difficult to explain the reason for these different results, our data are consistent with a generally accepted view that the AT 2 expression is minimal in adult kidney. 32 Although future studies are required to clarify the entire mechanism underlying complicated signaling cross-talk between cPLA 2 ␣ and ERK, a recent study also suggests the existence of arachidonic acid-dependent inhibitory pathway on the Ang IIinduced ERK activation in proximal tubular cells. 33 It remains unclear why higher concentrations of Ang II are required to activate cPLA 2 ␣ than to activate ERK in proximal tubules. It is tempting to speculate, however, that the relatively low-affinity response of intracellular Ca 2ϩ to Ang II ( Figure 4C ) is involved because the cPLA 2 ␣ activity is critically dependent on Ca 2ϩ -mediated translocation. 27 In AT 1A -deficient mice, on the other hand, high concentrations of Ang II could not activate cPLA 2 ␣ because of very low expression of AT 1B . Indeed, up to 10 Ϫ5 mol/L Ang II was unable to induce the intracellular Ca 2ϩ increase in AT 1A -deficient mice. 18 The generation of cPLA 2 ␣-deficient mice has revealed the important roles of this enzyme in a variety of biological processes such as anaphylaxis and tissue injuries. 23, 27, 34 Interestingly, deletion of cPLA 2 ␣ leads to dysregulation of IGF-1 signaling and promotes striated muscle hypertrophy. 35 Our study reveals that cPLA 2 ␣ also plays a pivotal role in renal Ang II actions. In particular, the identification of cPLA 2 ␣ as the principal negative regulator of Ang II actions is of great importance in understanding the transport regulation of proximal tubules, where exceedingly high concentrations of Ang II are found. 7 Indeed, a recent study shows that a high-salt diet, which suppresses the systemic Ang II concentration, paradoxically enhances the luminal Ang II concentration in rat proximal tubules to a level approaching the inhibitory range. 36 In addition, Ang II is known to promote the progression of chronic kidney disease by inducing multiple genes such as nucleus factors, hormones, hormone receptors, or cytokines. 37 Our study thus uncovers unrecognized roles of cPLA 2 ␣, which could have important influence not only on sodium homeostasis but also on kidney disease progression.
CONCISE METHODS
Animals
Male, wild-type, AT 1A -deficient, 22 and cPLA 2 ␣-deficient mice (5 to 8 wk old) 23 from the same genetic background (C57B6) were used in this study. They were provided with standard food and water ad libitum. All animal procedures were in accordance with local institutional guidelines.
Measurements of NBC Activity
NBC activity was determined as described previously. 18 In brief, the proximal tubule (S2 segment) fragment was microdissected manually and transferred to a perfusion chamber mounted on an inverted microscopy, and both ends of the tubule were sucked into two holding pipettes. To avoid the influence of luminal transporters, the luminally collapsed tubule was used. The tubule was incubated with an acetoxymethylester form of a pH-sensitive fluorescent dye, 2Ј,7ЈBCECF (BCECF; Dojindo, Kumamoto, Japan), and intracellular pH (pH i ) was monitored with a photometry system (OSP-10, Olympus, Tokyo, Japan). Prewarmed (38°C) DMEM, equilibrated with 5% CO 2 /95% O 2 gas, was used for the peritubular perfusate, which was shown to be essential for the long-term functional preservation of isolated proximal tubules. 18 
Measurements of Intracellular Ca 2؉ Concentrations
Intracellular Ca 2ϩ concentrations were measured as described previously. 18 Briefly, the tubules were incubated with 30 mol/L Fura-2/AM (Dojindo) for 60 min in DMEM under 5% CO 2 /95% O 2 gas. Thereafter, the tubule was transferred into the perfusion chamber, sucked into two holding pipettes, and intracellular Ca 2ϩ concentrations were measured on the OSP-10 system.
Measurements of the Rate of Bicarbonate Absorption
To measure JHCO 3 Ϫ , we used the stop-flow microspectrofluorometric method, which has been shown to be applicable for both rabbit and mouse proximal tubules. 19, 29, 40 Proximal tubules were microperfused according to the method previously described, 19 
Analysis of ERK Phosphorylation
For detection of ERK phosphorylation, thin slices of kidney cortex were obtained from mice. They were divided into pieces of small bundles, consisting mostly of proximal tubules as described. 40 These samples were incubated at 37°C for 40 min in DMEM under 5%CO 2 , which contained the angiotensin-converting enzyme inhibitor captoril (0.1 mol/L; Sigma) to suppress the endogenous production of Ang II. After Ang II was added for the indicated time in the absence or presence of several inhibitors, the samples were homogenized in an ice-cold buffer (25 mmol/L Tris-HCl (pH 7.4), 10 mmol/L sodium orthovanadate, 10 mmol/L sodium pyrophosphate, 100 mmol/L sodium fluoride, 10 mmol/L EDTA, 10 mmol/L EGTA, and 1 mmol/L phenylmethylsulfonyl fluoride) and centrifuged. Equal amounts (approximately 20 g) of protein samples were obtained from the supernatants, separated by SDS-PAGE, and transferred to a nitrocellulose membrane. The membrane was incubated with anti-ERK or anti-phospho-ERK antibodies (Cell Signaling Technology, Beverly, MA), and then with horseradish peroxidaseconjugated anti-rabbit IgG. The signals were detected on an ECL Plus system (Amersham, Aylesbury, UK). In some experiments, reblotting Western was performed to ensure equal sample loading and transfer.
After the ERK signals were obtained, the membrane was incubated with a stripping buffer containing 2% SDS and 100 mmol/L 2-mercaptoethanol for 30 min at 50°C, and was processed to another immunoblotting with the anti-phospho-ERK antibody.
Detection of mRNA for AT 1 Subtypes
Five fragments of proximal tubules (approximately 0.3 mm length each) were dissected from wild-type or AT 1A -deficient mice, and total RNA preparation and RT-PCR were performed with a High Pure RNA Tissue Kit (Roche, Basel, Switzerland) according to the manufacture's instruction. The first pair of primers was designed at the common sequences to amplify both AT 1A and AT 1B 41 : 5Ј-CCAAAGTCACCTGCATCATC-3Ј (sense) and 5Ј-CACAATCGC-CTAATTATCCTA-3Ј (antisense). The second pair of primers was designed to amplify the AT 1B specific sequences using the 3Ј-untranslated region: 42 5Ј-GCAGCATTTAGCTAGACAGTTC-3Ј (sense) and 5Ј-GCCTAGCAAATCTTAACACAC-3Ј (antisense). GAPDH mRNA was also amplified with the following primers: 43 5Ј-GGTCGGTGT-GAACGGATTTG-3Ј (sense) and 5Ј-GACGGACACATTGGGGG-TAG-3Ј (antisense). We followed all of the PCR protocols as described previously, [41] [42] [43] except that the number of PCR cycles was increased to 40 for each protocol.
Statistical Analyses
The data were represented as mean values Ϯ SEM. Significant differences were determined by applying the paired or unpaired t test as appropriate.
